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The Journal of Immunology
Loss of the Protein Tyrosine Phosphatase PTPN22 Reduces
Mannan-Induced Autoimmune Arthritis in SKG Mice
Shatakshi Sood,*,1 Rebecca J. Brownlie,*,2 Celine Garcia,* Graeme Cowan,*
Robert J. Salmond,*,2 Shimon Sakaguchi,† and Rose Zamoyska*
The cytoplasmic phosphatase, protein tyrosine phosphatase nonreceptor type 22 (PTPN22), is a negative regulator of T cell signaling.
Genome-wide association studies have shown that single-nucleotide polymorphisms in PTPN22 confer an increased risk of developing
multiple autoimmune diseases in humans. The precise function of PTPN22 and how the variant protein contributes to autoimmunity
is not well understood. To address this issue, we investigated the effect of PTPN22 deficiency on disease susceptibility in a mouse
model of autoimmune arthritis. The SKG mouse expresses a hypomorphic mutant allele of ZAP70, which, upon exposure to fungal
Ags, predisposes the mice to a CD4+ T cell–mediated autoimmune arthritis that closely resembles rheumatoid arthritis in humans.
Surprisingly, SKG Ptpn222/2mice developed less severe mannan-induced arthritis compared with SKG mice. Diminution of disease
was not due to significant alterations in thymocyte development or repertoire selection in SKG Ptpn222/2 mice, even though T cell–
mediated signal transduction was improved. Instead, Ptpn22 deficiency appeared to bias CD4 Th cell differentiation away from the
Th17 lineage, which is pathogenic in this setting, to a more Th1/T regulatory–focused response. These data show that even small
perturbations in TCR signal transduction pathways can have profound consequences on the differentiation of T cell lineages and thus
for the development of autoimmune diseases. The Journal of Immunology, 2016, 197: 000–000.
R
heumatoid arthritis (RA) is a chronic systemic inflam-
matory disease that predominantly affects the synovial
membranes of the primary joints. Although autoreactive
CD4+ T cells and dysregulated B cell homeostasis are prime
mediators of RA, the precise etiology remains unknown (1). Re-
cent genome-wide association analysis has identified a single-
nucleotide polymorphism, R620W, in the PTPN22 gene as a
predominant risk factor for RA and other autoimmune diseases
(reviewed in Ref. 2).
PTPN22 encodes a phosphatase known as lymphoid tyrosine
phosphatase in humans or proline, glutamic acid, serine, threo-
nine–enriched phosphatase in mice. The role of PTPN22 is best
characterized in T cells, where it functions to inhibit TCR sig-
naling by dephosphorylating key members of the T cell signaling
pathway, including Src family kinases such as Lck, ITAM residues
on TCR-z and CD3 chains, ZAP70, and Vav (3, 4). Ptpn222/2
mice show increased TCR signaling particularly in effector cells
with an age-dependent increase of effector-memory CD4+ and
CD8+ T cells (5, 6). On a C57BL/6 (B6) background, Ptpn222/2
mice do not show signs of autoimmunity (5, 6) unless the PTPN22
deletion is combined with another susceptibility mutation such as
CD45-E163R (7). PTPN22 R619W knock-in mice, which are
analogous to the human R620W variant and show a similar, albeit
milder phenotype to that of the Ptpn222/2 mouse (8, 9), were
found to develop multiple features of autoimmunity on a sus-
ceptible mixed B6/129 background (8). Collectively, these data
indicate that there is synergy between susceptibility alleles that
contribute to an autoimmune phenotype.
An association of PTPN22 dysfunction with autoimmunity fits
well with the known roles of phosphatases in attenuating signaling
pathways integral to immune cellular reactivity (10). However,
the underlying molecular mechanism by which PTPN22 regulates
the adaptive immune responses to contribute to maintenance or
breaking of tolerance is not well understood. Although a number
of PTPN22 targets have been identified in vitro, it is unclear which
of these are most relevant to the development of autoimmunity. To
address this issue, we used the ZAP70skg/skg (hereafter called
SKG) mouse that has a defect in ZAP70 kinase activity and ex-
pression and develops CD4+ T cell–mediated autoimmune arthritis
(11). In mice reared under specific pathogen-free conditions, ar-
thritis can be elicited either through activation of innate immunity,
by administration of fungal extracts, or by provoking homeostatic
proliferation of self-reactive T cells upon transfer to the T cell–
deficient environment (12). The SKG mouse has a spontaneous
point mutation in ZAP70, resulting in an amino acid change,
W163C within the Src homology 2 domain. ZAP70skg/skg homo-
zygous mice have a ∼80% decrease in ZAP70 protein abundance
compared with wild-type (WT) BALB/c mice and decreased sig-
naling through the TCR complex (11). Substrate trap experiments
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show that ZAP70 is one of the substrates of PTPN22, which de-
phosphorylates the activating tyrosine residue (Tyr493) on ZAP70
(4). We generated double-mutant SKG Ptpn22-deficient mice (SKG
Ptpn222/2) by backcrossing SKG mice with mice containing global
deletion of Ptpn22 to ask what influence combining these two
mutations would have on the development and progression of ar-
thritic disease.
We show that PTPN22 deficiency enhanced TCR-mediated sig-
naling in SKG Ptpn222/2 thymocytes and that the early stages of
thymus positive selection were partially restored in SKG Ptpn222/2
mice. However, the selected peripheral TCR repertoire of SKG
Ptpn222/2 mice was not substantially changed from that of SKG
mice. Consistent with increased signaling observed in the thymo-
cytes, there were improved in vitro proliferation and IL-2 produc-
tion of CD4+ T lymphocytes from SKG Ptpn222/2 mice compared
with SKG mice. Surprisingly, SKG Ptpn222/2 mice developed less
severe mannan-induced arthritis than SKG mice and showed de-
creased proportions of Th17 and slightly higher numbers of T
regulatory cells (Tregs). Therefore, the absence of PTPN22 partially
compensates for the defect in ZAP70 activity in the SKG mouse.
The increase in TCR signaling capacity influenced the differentia-
tion outcomes of SKG Ptpn222/2 Th cells with a corresponding
decrease in the incidence of autoimmune disease.
Materials and Methods
Mice
Ptpn22 Exon1fl/fl 3 PC3-Cre (global Ptpn222/2) (5) mice were back-
crossed onto the ZAP70Skg/Skg mouse line (11) for more than eight gener-
ations to generate SKG Ptpn222/2 double-mutant mice. BALB/c Rag22/2
and BALB/c mice were bred in house. All mouse strains used were main-
tained and bred under specific opportunistic pathogen-free conditions, at the
University of Edinburgh animal facilities, and experiments were conducted
in accordance with the United Kingdom Animals (Scientific Procedures)
Act, 1986, and local ethically approved guidelines.
Cell purification
Single-cell suspensions from lymph nodes (LNs) of BALB/c, SKG, and
SKG Ptpn222/2 mice were stained with anti-MHC class II (M5114) and
CD8a (53-67.2) rat Abs and enriched by negative selection using sheep
anti-rat IgG Dynabeads (Life-Technologies), according to the manufac-
turer’s instructions. The negatively enriched CD4+ T cell population was
then sorted on a FACSAria I (BD Biosciences) to obtain pure populations
of CD4+CD252CD45RBhi naive T cells (.99% purity).
Flow cytometry and Abs
Cells were resuspended in FACS buffer (PBS containing 1% FCS and
0.05% sodium azide) and incubated with Abs for 30 min on ice, followed
by washes in FACS buffer before acquisition on MACSQuant (Miltenyi
Biotec) or LSR-II (BD Biosciences) flow cytometers and analyzed using Flow
Jo software v9.6 (Tree Star). Fluorophore-conjugated mAbs against the fol-
lowing Ags were from eBioscience: CD3-bio (145-2C11), CD8-PE (53-6.7),
CD25-allophycocyanin (PC61.5), CD44-allophycocyanin eFluor 780 (IM7),
CD45RB-PE (C363.16A), CD62L-PE (MEL-14), TCR-FITC and -biotin
(H57-597), IL-17 allophycocyanin (ebio17B7), Vb3-FITC (KJ25), Vb5-
PerCP (MR9.4), Vb8.1/8.2-PE (KJ16), and Vb11-FITC (CTVB11). The
following Abs were purchased from BioLegend: CD4-Pacific Blue and
-PerCP (RMA 4-5), CD8-PerCP (53-6.7), CD69-biotin (H1.2F3), and IFN-
g-FITC (XMG1.2). CFSE and Cell Tracer Violet were purchased from
Invitrogen. For intracellular staining, LN cells prestained with CD4 Ab were
stimulated with 50 ng/ml phorbol 12,13-dibutyrate (PDBu; Sigma-Aldrich)
and 0.5 mg/ml ionomycin (Sigma-Aldrich) in the presence of 5 mg/ml bre-
feldin A (Sigma-Aldrich) for 4 h, stained with Live/Dead (Molecular Probes,
Invitrogen), fixed and permeabilized with Cytofix/Cytoperm (BD Biosci-
ences), and stained with cytokines anti–IL-10, anti–IL-17, anti-TNF, and
anti–IFN-g. The data were collected using a MacsQuant (Miltenyi Biotec)
flow cytometer and analyzed using FlowJo software v9.6 (Tree Star).
Western blotting
Cells were lysed in 1% Triton X-100, 0.5% n-dodecyl-b-D-maltoside,
50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 20 mM EDTA, 1 mM NaF, and
1 mM sodium orthovanadate containing protease inhibitors, and samples
were separated by SDS-PAGE. Membranes were incubated in blocking
reagent (LI-COR Biosciences) before immunoblotting with Abs to ZAP70
and b-actin. Proteins were detected with secondary Abs and visualized
using an infrared imaging system (Odyssey; LI-COR Biosciences).
Calcium flux
Single thymocyte cell suspension, 1 3 107 cells/ml in prewarmed PBS,
from BALB/c, SKG, and SKG Ptpn222/2 mice were labeled with varying
concentration of CFDA-SE dye (Life Technologies) for 10 min, protected
from light at 37˚C. The individual populations were mixed in a 1:1:1 ratio
at final cell concentration of 3 3 107 cells/ml and incubated with 2 mM
solution of the ratiometric indo-1-AM dye (Life Technologies) for 40 min
at 37˚C in prewarmed PBS, before washing and staining with 10 mg/ml
biotinylated anti-TCR (H57-597), anti-CD3 (145-2C11), and anti-CD4 (RMA
4.5) mAbs. Anti–CD8a-PerCP (53-6.7) and anti–CD4-allophycocyanin
(RMA4.4) Abs were used to identify the thymus populations. After the
surface staining, cells were resuspended in prewarmed IMDM (Life
Technologies) containing 1% FCS and supplemented with 2.5 mM CaCl2
and 2.8 mM MgCl2. The baseline Ca
2+ levels were measured for 45 s
before cross-linking the biotinylated Abs with 1 mg/ml streptavidin–
PE conjugates, and samples were collected on a flow cytometer (LSR
II; BD Biosciences). The increase in Ca2+ was measured as the ratio
of Indo-1-violet to Indo-1-blue fluorescence and displayed as func-
tion of time.
TCR repertoire analysis
mRNA was purified from 106 naive CD4 T cells using a mRNA direct
purification kit (ThermoFisher Scientific), and cDNA was synthesized
using SMARTscribe reverse transcriptase (Clontech Laboratories) to pro-
duce bead-coupled mRNA libraries. The entire volume of mRNA beads
was added to 4 mL first-strand buffer, 0.5 mL 20 mM DTT, 2 mL 10 mM
dNTP mix, 2 mL SMART synthesis oligo (59-GGCGAAGCAGTGGTAT-
CAACGCAGAGTACGCrGrGrG-39), 0.5 mL RNase inhibitor, and 2 ml
SMARTscribe reverse transcriptase (Clontech), and the reaction was in-
cubated at 42˚C for 1 h.
TCR-b V-region amplicons were generated from cDNA by PCR using
indexed forward primers composed of the SMART synthesis oligo sequence
fused to a P7 illumina tag, and a reverse primer within the TCR-b C region
fused to a P5 illumina tag. Amplified products were purified by extraction
from excised agarose gel bands and concentrated by ethanol precipitation
prior to sequencing. Single-end 13 400-bp sequencing was performed on an
Illumina MiSeq sequencer using custom read1 primers and indexing primers
complementary to the amplification primer sequences. Sequence data were
processed using the MiTCR utility (13) and a customized pipeline of python
scripts to analyze and plot the MiTCR output.
Cell cultures and assays
Cells were cultured in IMDM (Sigma-Aldrich) supplemented with 5% heat-
inactivated FBS (Serotec), 2 3 1023 M L-glutamine, 100 U/ml penicillin,
100 mg/ml streptomycin, and 5 3 1025 M 2-ME (Sigma-Aldrich). Sorted
naive CD4+ T cells were labeled with 2.5 mM Cell Trace Violet (Molecular
Probes, Life Technologies) in prewarmed PBS at 37˚C for 20 min in dark
and washed, and 1 3 105 Cell Trace–labeled T cells were incubated with
2 3 105 irradiated BALB/c Rag22/2 splenocytes in presence of 0.04, 0.2,
and 1 mg/ml anti-mouse CD3ε Abs (eBioscience) in round-bottomed 96-
well plate at 37˚C. Cells were harvested at 72 h after stimulation and
stained with anti-CD4 and anti-CD8, and proliferation was assessed and
analyzed by flow cytometry. Supernatants from stimulated LN cultures
were analyzed for IL-2 by ELISA with paired capture and detection Ab
from eBioscience. Plates (NUNC Maxisorp) were washed with 0.05%
Tween 20 in PBS and blocked with blocking buffer (supplied with kit).
Supernatant samples were analyzed in triplicates. After the addition of 100
mL 3,39, 5,59 tetramethylbenzidine substrate solution (supplied with kit)
and 100 mL 0.18 M H2SO4 (Carl Roth), absorbance was read at 450 nm
with a Laboratory Systems Multiscan Ascent plate reader.
For in vitro Th17 induction, 53 105 sorted naive CD4+ T cells from LNs
were in cultured 1 ml media in a 48-well plate and stimulated with
immobilized anti-CD3 (1.5 mg/ml) and anti-CD28 (3 mg/ml) in the pres-
ence of a mixture of the following cytokines: TGF-b (1 ng/ml), IL-1b
(10 ng/ml; PeproTech), IL-23 (10 ng/ml; R&D Systems), FICZ (300 nM;
Enzo Life Science), IL-6 (20, 2, 0.2, 0.02 ng/ml; eBioscience), anti–IFN-g
(5 mg/ml R4-6A2; eBioscience), anti–IL-2 (JES 6-1A12; BioLegend), and
anti–IL-12 and anti–IL-4 (from BD Pharmingen) for 4 d. At the end of the
culture, the cells were harvested and restimulated with PDBu and ion-
omycin before intracellular staining and analysis by flow cytometry.
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Peritoneal exudate cells from unimmunized mice were adhered to plastic
for 4 h and washed before adding mannan. Twenty-four hours later, su-
pernatants were harvested, and the remaining cells were lysed for analysis of
protein content. IL-6 was assayed using an ELISA kit (eBioscience), and the
IL-6 concentrations obtained from a standard curve were normalized to the
protein values per well.
For the in vivo Treg suppression assay, FACS-sorted naive BALB/c
CD90.1+CD4+CD252CD45RBhi cells (4 3 105) were injected alone or
together with FACS-sorted SKG or SKG Ptpn222/2 CD45.2+CD4+CD25+
Tregs (2 3 105) i.v. into BALB/c Rag22/2 recipients in a 2:1 ratio, as
indicated (n = 6 mice per group). After 12 d, LNs were assessed by flow
cytometry for their proportions of CD90.1+Foxp32 naive cells and
CD90.12Foxp3+ Tregs.
Induction and scoring of arthritis
Six- to eight-week-old mice were injected once i.p. with 50–75 mg mannan
reconstituted in sterile PBS. Mice were weighed and observed for clinical
signs of arthritis weekly for 4 wk. Signs of arthritis were assessed by visual
scoring where 0 = no joint swelling, 1 = mild to moderate swelling, 2 =
substantial swelling of wrist or ankle, and 3 = severe swelling of wrist or
ankle. Scores for all the wrists and ankles were combined for each
mouse.
Results
Absence of Ptpn22 does not alter selection in SKG thymocytes
In SKG mice, decreased signaling results in defective positive and
negative thymic selection (11). In contrast, Ptpn22 deficiency has
little apparent influence on thymus selection in B6 mice (5, 6).
However, in the context of Ptpn22 deficiency, there was a report of a
slight increase in selection of CD4 cells, but no change in negative
selection on a TCR transgenic background (6, 7). Therefore, we
asked whether loss of PTPN22 would improve selection of thy-
mocytes on the SKG background.
SKG mice have a ∼4-fold decrease in the abundance of ZAP70
protein (11). The absence of PTPN22 did not alter ZAP70 pro-
tein abundance with SKG Ptpn222/2 thymocytes having a similar
reduction compared with BALB/c mice (Fig. 1A). SKG thymocytes
develop normally until the double-positive (DP) stage (11) in
keeping with a limited role for ZAP70 in earlier stages of thymus
differentiation (14). Consistent with this, analysis of thymocytes
from SKG and SKG Ptpn222/2 mice showed that loss of
PTPN22 had little effect on the proportions (Fig. 1B) and ab-
solute numbers (Table I) of double-negative and DP thymocytes
between these two strains, although total thymocyte numbers for
both were reduced relative to control thymocytes from BALB/c
mice (11).
In SKG mice, impaired ZAP70 expression, and therefore
function, leads to a failure of both positive and negative selection
(11). There was a major reduction in the proportion of TCRhigh DP
thymocytes in SKG mice (11), and we saw an equivalent reduction
in the SKG TCRhigh DP subpopulation in the absence of PTPN22
(Fig. 1C). SKG DP thymocytes have lower CD5 expression than
BALB/c DPs, whereas levels of CD5 expression on SKG Ptpn222/2
and BALB/c DP thymocytes were similar (Fig. 1C). The higher
expression of CD5 on DP thymocytes in the absence of PTPN22
was consistent with reports from Ptpn222/2 mice on the C57BL/6
background (5, 6); however, the upregulation of CD5 at this stage
did not seem to impact on subsequent selection events. Detailed
analysis of the stages of positive selection can be identified by
gating DP thymocytes on CD5 and TCR expression to reveal three
stages of maturation, as follows: DP1 (CD52TCR2), DP2 (CD5int
TCRint), and DP3 (CD5int TCRhi) (Fig. 1D) (15, 16). The abun-
dance of both CD5 and TCR depends on the levels and function of
ZAP70 (17), and consequently SKG mice have a lower proportion
of DP2 and DP3 cells compared with BALB/c mice, whereas the
proportions of DP2 and DP3 subsets were slightly elevated in
SKG Ptpn222/2 mice compared with SKG mice (Fig. 1E). Se-
lection signals can also be monitored by CD69 upregulation. In
BALB/c thymocytes, CD69 expression increased progressively as
the cells transited from DP1 to DP3, consistent with these sub-
populations becoming positively selected. Although both SKG
and SKG Ptpn222/2 thymocytes upregulated CD69 between DP1
and DP2 subsets, thereafter CD69 expression was unchanged
(Fig. 1F). These data suggest that selection signals at this later
stage in the SKG background strains of mice are not maintained to
the same extent as they are in BALB/c mice. Indeed, in both SKG
and SKG Ptpn222/2 thymuses, there were significantly fewer
mature CD4 SP and CD8 SP cells generated than in BALB/c mice
(Table I), consistent with the impaired positive selection described
previously for SKG mice (11). However, there was no significant
change in the overall numbers of positively selected thymocytes
between SKG and SKG Ptpn222/2 mice.
Given that ZAP70 has been reported to be a target of PTPN22,
we asked whether we could detect differences in signaling through
the TCR between SKG and SKG Ptpn222/2 DP thymocytes. To
control the timing of the delivery of the TCR signal between the
individual samples, thymocytes from BALB/c, SKG, and SKG
Ptpn222/2 mice were labeled with different amounts of CFSE so
that they could be mixed together in a 1:1:1 ratio and yet distin-
guished by FACS. Cells were stimulated by incubating with bio-
tinylated Abs that were cross-linked by addition of streptavidin.
Cross-linking CD3 with CD4, but not TCR alone, induced a robust
peak of intracellular Ca2+ flux in WT BALB/c DP thymocytes,
whereas Ca2+ flux in SKG thymocytes was impaired, as has been
reported previously (11) (Fig. 2A). The absence of PTPN22 par-
tially restored the ability of CD3 plus CD4 cross-linking to induce
a Ca2+ flux in the SKG DP cells, although it remained lower than
WT BALB/c control (Fig. 2A).
In BALB/c mice, thymocytes expressing TCRVb3, Vb5, Vb11,
and Vb12 chains are reactive with endogenous viral superantigens
encoded by Mtv-8 and Mtv-9, and are consequently deleted (18).
A graded decrease in TCR signal strength by the expression of
aberrant ZAP70 was shown to lead to failure of deletion of self-
reactive autoimmune clones in the thymus and thus to alter the
peripheral TCR repertoire (19). SKG mice were shown to have an
increased frequency of thymocytes bearing these TCR Vb sub-
families, indicating a failure of negative selection (20). Given that
lack of PTPN22 partially restored Ca2+ signaling in DP thymo-
cytes, and the strength of Ca2+ signaling is directly linked with
induction of negative selection at this stage (21), we sought to
determine whether there was any effect of Ptpn22 deficiency on
deletion of these particular TCR Vb families. As described pre-
viously (18), the frequency of mature CD4+ single-positive (SP)
thymocytes and CD4+ peripheral T cells expressing TCR Vb3,
Vb5, or Vb11 chains was increased in SKG as compared with
BALB/c mice (Fig. 2B). Additionally, there was a compensatory
decrease in the proportion of TCR Vb8.1/8.2+ cells in SKG mice
(20). Loss of PTPN22 did not impact on this failure of negative
selection on the SKG background, as there was no significant
difference in the proportions of these specific TCR Vb-expressing
cells in either the thymus or periphery of SKG Ptpn222/2 com-
pared with SKG mice (Fig. 2B). This result agrees with previous
studies reporting that PTPN22 has minimal role in negative se-
lection (6). Overall, these data indicate that PTPN22 deficiency
does not impact substantially on either positive or negative se-
lection in the thymus of SKG background mice. We observed a
small, but significant increase in Vb11-expressing T cells in the
periphery of SKG Ptpn222/2 compared with SKG mice, which
was not apparent in the thymus, and it may be that exposure to
viral superantigens in the periphery causes greater expansion of
this Vb subset in the absence of PTPN22.
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Similar TCR repertoire but increased responsiveness of SKG
Ptpn222/2 CD4+ T cells
To address more specifically whether the peripheral repertoire was
similar between SKG and SKG Ptpn222/2 mice, we sequenced
their TCR-b CDR3 regions. Naive CD4+ T cells were sorted from
LN of naive BALB/c, SKG, and SKG Ptpn222/2 mice, and TCR-
b CDR3 sequences were obtained by next generation sequencing.
Linear regression analysis of the TCR Vb repertoires between
BALB/c and SKG or BALB/c and SKG Ptpn222/2 mice showed
there were considerable differences in VJ usage, indicated by the
poor r2 values, 0.87 and 0.85, respectively, in comparison with
that between SKG and SKG Ptpn222/2 T cells, which were highly
FIGURE 1. The absence of Ptpn22 does not alter selection in SKG thymocytes. (A) The abundance of ZAP70 protein in thymocytes from age-matched
(7-wk) BALB/c, SKG, and SKG Ptpn222/2 mice was assessed by Western blotting of total cell lysates with ZAP70-specific Ab and b-actin Ab as loading
control. Relative expression of ZAP70 was calculated by normalizing the fluorescence of bands to WT BALB/c band. (B) Ptpn222/2mice were assessed for
the proportions of double-negative, DP, CD4 SP, and CD8 SP thymocytes by flow cytometry. Numbers on the plots denote the averages6 SD of a minimum
of three individual mice per group. Data are representative of four independent experiments. (C) Histograms show surface expression of ab-TCR and CD5,
as indicated, on gated DP thymocytes. (D) Staining of thymocytes with Abs to CD5 and TCR-b was used to distinguish the stages of DP maturation: DP1
(TCRloCD5lo), DP2 (TCRintCD5int), and DP3 (TCRhiCD5int), as indicated. (E) Graphs representing the proportion of thymocyte subpopulation in the DP1,
DP2, and DP3 gate. Data represent an average of six to nine mice per genotype (6SD) from three independent experiments. Statistical significance
calculated with one-way ANOVA and post hoc Holm–Sidak test for multiple comparisons. *p , 0.01, ***p , 0.0001. (F) FACS histogram plots show
progressive upregulation of CD69 on DP1, DP2, and DP3 thymocytes from the indicated mouse strains.
Table I. Comparison of thymocyte subpopulation numbers in BALB/c, SKG, and SKG Ptpn222/2 mice
Genotype Total DN DP CD4 SP CD8 SP
BALB/c (n = 9) 125.2 6 13.8 7.0 6 2.7 98.1 6 8.8 3.2 6 1.0 1.9 6 0.9
SKG (n = 9) 113.3 6 3.2 4.7 6 1.5 102.5 6 3.5 0.5 6 0.1 0.06 6 0.04
SKG Ptpn222/2 (n = 12) 112.1 6 10.4 4.7 6 3.0 100.8 6 9.6 0.7 6 0.3 0.1 6 0.07
Thymocytes were obtained from 7-wk-old age-matched mice, and the absolute number within each subpopulation was calculated based on the expression of the markers CD4
and CD8 using the gating strategy shown in Fig. 1B.
DN, double negative.
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correlated, r2 = 0.96 (Fig. 3A). More detailed analysis represented
by heatmaps of V versus J segment usage showed that there were
some subtle changes in VJ usage between the SKG and SKG
Ptpn222/2 populations (Supplemental Fig. 1A). However, these
differences were found to be due to a few VJ combinations that
were represented at very low frequencies in SKG or BALB/c
repertoires, and were slightly increased in SKG Ptpn222/2 mice
(Supplemental Fig. 1B). It had been shown previously (22) that
arthritogenic T cells in the SKG model were found among TCRs
expressing Vb6, Vb8.1/8.2, and Vb10 gene segments. We ex-
amined the representation of these specific Vb alleles among the
TCR sequence data and found these Vbs to be at least equally, if
not slightly more represented in the absence of PTPN22 (Fig. 3B).
Overall, the repertoires of SKG and SKG Ptpn222/2 naive CD4
T cells were highly similar, and quite distinct from that of BALB/c
mice, further confirming that loss of PTPN22 had little effect on
the selection of the naive SKG TCR repertoire.
We asked whether Ptpn22 deficiency in SKG T cells was able to
compensate for the reduced expression of ZAP70 and improve
their response to TCR stimulation. Naive CD4+ T cells, gated as
CD45RBhiCD252, were sorted from LNs of young (6-wk-old)
BALB/c, SKG, and SKG Ptpn222/2 mice, and proliferation was
measured following stimulation with anti-CD3 Ab and irradiated
splenocytes from BALB/c Rag22/2 mice as APC. As previously
reported, there was decreased proliferation of SKG CD4+ cells
compared with that of WT BALB/c in response to all doses of
anti-CD3 after 72 h of stimulation in vitro (Fig. 3C, 3D) (11).
Although the proliferation of SKG Ptpn222/2 cells was reduced
compared with BALB/c T cells, SKG Ptpn222/2 cells proliferated
significantly more than SKG cells, particularly at lower concen-
tration of anti-CD3, as indicated by the division index (Fig. 3C,
3D). In addition, we measured IL-2 cytokine production follow-
ing stimulation. Although considerably less than produced by
WT BALB/c T cells (compare different axes between SKG and
BALB/c), SKG Ptpn222/2 cells produced more IL-2 than SKG T
cells at all anti-CD3 concentrations (Fig. 3E).
Ptpn22 deficiency decreases the incidence and severity of
arthritis in SKG mice
The frequency and clinical score of spontaneous arthritis in SKG
mice are dependent on the cleanliness of the environment and
microbial colonization. In our animal facilities, SKGmice up to the
age of 6 mo did not develop any spontaneous arthritis or any
systemic inflammation such as interstitial pneumonitis, as previ-
ously reported (23), and loss of PTPN22 did not make them any
more susceptible to spontaneous disease up to ∼8 mo of age.
It has been shown that autoimmune disease can be triggered by a
single i.p. injection of fungal extracts, such as zymosan, a crude
yeast wall extract (12), or mannan, a fungal wall polysaccharide
(24). We were unable to elicit any signs of arthritis with the
published doses of mannan (0.2, 2, and 20 mg) (25), possibly
because, rather than being specific pathogen free (SPF), our mice
are of specific opportunistic pathogen-free health status, which
may impact on the generation of Th17 T cells (26, 27). Therefore,
we used a higher dose of mannan of 50 mg/mouse to provoke
disease. A single i.p. injection of 50 mg mannan triggered joint
inflammation in both SKG and SKG Ptpn222/2 mice. Contrary to
expectation, Ptpn22 deficiency delayed the onset and severity of
arthritis in SKG mice. Moreover, the incidence of disease was
decreased in SKG Ptpn222/2 mice with 3 of the 10 SKG Ptpn222/2
mice failing to develop any symptoms of arthritis, compared with
only 1 of 10 SKG mice (Fig. 4A). Arthritic joints from mannan-
treated SKG and SKG Ptpn222/2 mice with comparable arthritis
scores showed similar levels of cellular infiltrates (data not shown);
however, loss of PTPN22 decreased both the likelihood of getting
disease and the overall severity of the resulting arthritis (Fig. 4B).
IL-6 is a key cytokine for the development of arthritogenic Th17
cells in SKG mice, and mannan stimulates IL-6 production by
macrophages. We tested whether there was a difference in IL-6
production by SKG or SKG Ptpn222/2 peritoneal macrophages
after exposure to a range of mannan concentrations, and found
the response to be equivalent for both genotypes (Fig. 4C). It is
unlikely, therefore, that differences in innate cell responses to
FIGURE 2. Thymocytes from SKG Ptpn222/2 show en-
hanced TCR-induced calcium mobilization compared with
SKG mice. (A) Single suspension of BALB/c, SKG, and SKG
Ptpn222/2 thymocytes was labeled with different concentra-
tion of CFSE: 0, 0.012, and 0.002 mM, respectively, mixed in
1:1:1 ratio, and loaded with 2 mM indo-1 dye. Samples were
stained with directly conjugated Abs to CD4 (epitope A) and
CD8, followed by biotin-conjugated Abs to either TCR-b or
CD3 + CD4 (epitope B). Baseline was established for 45 s on
gated DP cells, as indicated, and induction of Ca2+ flux was
achieved by addition of cross-linking streptavidin–PE conju-
gates. Arrows on the histogram indicate the time of addition of
streptavidin (45 s) and ionomycin (8 min) as positive control.
Data are representative of three independent experiments. (B)
Graphs show expression of TCR Vb3, Vb5, Vb11, and Vb8
alleles in gated mature CD4+CD5hi thymocytes (left) and pe-
ripheral CD4+ T cells (right) for the individual mouse strains,
as indicated. The data are representative of three independent
experiments and are shown as averages of n = 4 for each strain
6 SD. Statistical significance was calculated by one-way
ANOVA and post hoc Holm–Sidak test for multiple compar-
isons. ***p , 0.0001.
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mannan were responsible for the resistance to arthritis in the SKG
Ptpn222/2 background.
Loss of PTPN22 does not affect Treg numbers or function on
the SKG background
We and others (5, 28) have previously reported that Ptpn222/2
mice on the B6 background have an increase in Treg numbers.
Furthermore, on a per cell basis, Ptpn222/2 Tregs were more
potent than WT Tregs and suppressed colitis induced by Ptpn222/2
effector cells, which WT Tregs were unable to control (5). We
examined whether increased Treg production or efficacy accounted
for the reduced arthritis found in the SKG Ptpn222/2 mice.
TCR signal strength is crucial in development of thymic Tregs
(29), and the decrease in TCR signaling capacity in SKG mice
results in a decrease in the proportion of thymic Tregs (19). Given
that SKG Ptpn222/2 mice had slightly improved signaling in DP
thymocytes (Fig. 2A), we asked whether they had any changes in
proportions of thymic Tregs. Both the percentages and the abso-
lute cell numbers of FoxP3+ cells were similar in the thymuses of
SKG Ptpn222/2 and SKG mice (Fig. 5A), indicating comparable
efficiency of selection of Tregs between these strains. The overall
numbers of thymic Tregs in SKG were significantly reduced
compared with control BALB/c mice (Fig. 5A), as reported pre-
viously (19).
FIGURE 3. Similar TCR repertoires, but enhanced responsiveness of SKG Ptpn222/2 peripheral CD4 T cells. (A) Linear scatterplots comparing the fre-
quency of each V/J allelic combination between each pair of mouse genotypes are shown. Best-fit straight lines are plotted for each pairwise comparison, and
the corresponding value for goodness-of-fit (r2) is indicated. (B) The frequency of individual Vb-containing sequences expressed as a percentage of the total
repertoire is shown for alleles that have been reported to induce arthritis in SKG mice. (C) Sorted naive CD4+ T cells (CD252CD45RBhi) from BALB/c,
SKG, and SKG Ptpn222/2 mice (105 cells/well) were stimulated with anti-CD3 and anti-CD28 (2 mg/ml) for 72 h. Proliferation was measured by
dilution of Cell-Tracer violet, as shown in the histograms, and (D) division index was calculated using FlowJo software. Data representative of four
independent experiments. (E) Supernatants were harvested and assayed for IL-2 by ELISA. Results are presented as mean 6 SD of triplicate samples
and are representative of three independent experiments. Statistical significance was calculated using two-way ANOVA; ns, nonsignificant; *p , 0.05,
**p , 0.001.
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Compared with BALB/c mice, numbers of T effector/memory
cells and peripheral Tregs are increased in SKG mice, as the re-
duced generation of SP thymocytes results in a more lymphopenic
peripheral environment (19). Comparison of Treg numbers in
peripheral lymphoid organs of SKG Ptpn222/2 and SKG mice
showed that the former had a small, but significant increase in the
numbers of CD25+FoxP3+ Tregs in spleen of adult animals
(Fig. 5B). This change was confined to the spleen, as LNs from
these mice showed comparable numbers of Tregs irrespective of
Ptpn22 status (Fig. 5C). We further assessed whether PTPN22
deficiency influenced Treg expansion upon mannan challenge.
Compared with either untreated SKG or BALB/c control mice,
increased proportions of Tregs were recovered from LNs and
spleen in mannan-treated SKG and SKG Ptpn222/2 mice
(Fig. 5D). We noted a consistent, albeit not statistically significant,
increase in the proportions of Tregs in the LN and spleen of SKG
Ptpn222/2 compared with SKG mice. Furthermore, a significant
increase in the proportions of Tregs in the mesenteric LN, a key
site of inducible Treg induction, was seen in SKG Ptpn222/2
mice, suggesting that Ptpn22 deficiency might enhance the pro-
pensity of naive T cells to differentiate into this lineage (Fig. 5D).
We tested the ability of SKG and SKG Ptpn222/2 Tregs to
suppress expansion of naive BALB/c T cells in vivo by cotransfer
into empty Rag2/2 mice. In the absence of Tregs, the naive T cells
expanded in the empty hosts, and the expansion was controlled to
a similar extent by Tregs from either SKG or SKG Ptpn222/2
mice (Fig. 5E). Therefore, on the SKG background, PTPN22-
deficient Tregs are not more suppressive than SKG Tregs, in
contrast to our previous findings that Tregs from C57BL/6 mice
with normal ZAP70 expression are more potent suppressor cells
when PTPN22 is absent (5). Given this result, we conclude that,
although there was a slight increase in Treg numbers when
PTPN22 was absent, it is unclear that this increase in numbers
alone would have sufficient impact to account for the resistance to
arthritis in this model.
Effector SKG Ptpn222/2 CD4 T cells have reduced propensity
to polarize to the Th17 lineage
On the B6 background, there is an expansion of Ptpn222/2 T
effector/memory cells with age (5, 6). Perturbations in T cell
homeostasis are linked to onset of autoimmunity and are seen
with autoimmune-prone PTPN22R620W-expressing individuals
(30), so we asked whether there was equivalent expansion of ef-
fector cells in SKG mice or whether the SKG phenotype might
suppress PTPN22-mediated expansion and thus explain the re-
duced arthritis in SKG Ptpn222/2 mice. We analyzed the T cell
phenotype of young (∼6 wk of age) and older ($21 wk) at 6 wk
and saw a small, but not statistically significant increase of ef-
fector cells (CD44hi CD62Llo) on the SKG background compared
with BALB/c and no difference between SKG and SKG Ptpn222/2
mice. In older animals, SKG Ptpn222/2 mice showed a clear ex-
pansion of effector cells, which was significantly greater than that
seen in SKG mice, which in turn were significantly expanded
compared with BALB/c mice (Fig. 6A). Analysis of the cytokine-
producing potential of CD4 T cells from these animals ex vivo
showed that, compared with BALB/c cells, both SKG and SKG
Ptpn222/2 CD4 T cells from LN had an increased, but similar
capacity to produce IL-17, whereas the incidence of IFN-g–pro-
ducing cells was not significantly different between the strains
(Fig. 6B). A higher incidence of IL-17–producing cells has been
noted for SKG mice (25), although the percentage of spontaneous
Th17+ cells is considerably lower in our animal facility than pre-
viously published, presumably reflecting different exposure to
commensal microbiota.
Development of arthritis in SKG mice is dependent on IL-17–
producing arthritogenic Th17 cells, which are promoted by IL-6
secreted predominately by APCs (31). Deficiency of either IL-6 or
IL-17 completely inhibits the arthritis, whereas lack of IFN-g can
exacerbate disease in SPF mice (31, 32). As SKG Ptpn222/2 mice
developed less severe arthritis than SKG mice, we compared
FIGURE 4. Milder mannan-induced arthritis in SKG Ptpn222/2 mice.
(A) Incidence of arthritis and (B) joint scores from 11- to 12-wk-old female
SKG and SKG Ptpn222/2 mice that received 50 mg mannan i.p. Data
representative of two independent experiments. Error bars are mean 6 SD
of the arthritis scores. Statistical significance for the mean arthritis score
was calculated using a paired t test; ns, nonsignificant; *p , 0.05, **p ,
0.001, and Mantel Cox test was used to assess the significance of arthritis
incidence. (C) Peritoneal lavage macrophages were adhered to plastic and
stimulated overnight with the indicated concentrations of mannan. Su-
pernatants were harvested at 24 h and assayed for IL-6 production by
ELISA. Data are the means 6 SD of duplicate samples from two bio-
logical replicates, and represent one of two independent experiments.
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cytokine production in peripheral CD4+ T cells in these animals
following injection of mannan and induction of arthritis. Periph-
eral and mesenteric LNs were isolated separately from mice 14 d
after mannan injection and stained for cytokine production after a
brief stimulation with PDBu and ionomycin. Production of key
cytokines IL-17 and TNF-a (Fig. 7A, 7B) was significantly re-
duced in SKG Ptpn222/2 mice following arthritis induction
compared with SKG mice. IL-17–producing cells from both
mouse strains were CD4+, ab-TCR+, and CCR6+, indicating they
were conventional Th17 cells (data not shown). There was a
tendency of SKG Ptpn222/2 mice to produce more IFN-g–se-
creting cells (Fig. 7C); however, this was significant only in the
FIGURE 5. Treg numbers are similar in SKG and SKG Ptpn222/2 mice. (A) Representative FACS plots and total cell numbers of Tregs present in the
thymus of 7-wk-old mice show no difference between SKG and SKG Ptpn222/2 mice. (B) Older mice, .21 wk old, on the SKG background show
expansion of Tregs in the spleen compared with BALB/c mice, and there was a statistically significant increase in absolute numbers of Tregs between SKG
and SKG Ptpn222/2 mice. (C) In contrast, LN Treg proportions and numbers are equivalent in SKG and SKG Ptpn222/2 mice, although raised in
comparison with BALB/c mice. Each symbol in (A-C) represents an individual of six to nine mice total, and bars represent SD. Statistical significance was
calculated using a Kruskal–Wallis test with Dunn’s posttest, adjusted for multiple comparisons. (D) Proportions of Tregs were expanded to a similar extent
in SKG, and SKG Ptpn222/2 mice 3 wk following mannan treatment, with only MLN, showed a slight but significant increase of Tregs in the absence of
PTPN22. Each symbol represents an individual of six mice total per genotype (6SD) from two independent experiments. (E) In vivo Treg suppression
assay. WT sorted BALB/c naive CD90.1+CD4+ cells (4 3 105) were injected alone or together with SKG or SKG Ptpn222/2 CD45.2+CD4+CD25+ Tregs
(23 105) into BALB/c Rag22/2 recipients (n = 6 mice per group). After 12 d, recovery of CD90.1+Foxp32 T cells was determined. Each symbol represents
individual mouse. Bars represent SD. Statistical significance was calculated using one-way ANOVA and post hoc Tukey’s test for multiple comparisons.
*p , 0.05, **p , 0.005, ***p , 0.0005.
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mesenteric LNs. To ascertain whether the reduced tendency of
cells from SKG Ptpn222/2 to differentiate to the IL-17 lineage
was cell intrinsic or a consequence of the cytokine milieu, we
differentiated purified naive CD4+ T cells from SKG and SKG
Ptpn222/2 mice in vitro in the presence of increasing concen-
trations of IL-6 together with TGF-b. Significantly fewer IL-17–
producing cells were generated from SKG Ptpn222/2 CD4 T cells
than from SKG mice (Fig. 7D, 7E), suggesting that loss of PTPN22
produces an inherent bias against polarization to the IL-17 lineage
that may contribute to the reduction in susceptibility to arthritis
observed in this strain of mice.
Discussion
In this study, we examined the influence of the phosphatase PTPN22
on the development of autoimmune disease in combination with an
established model of autoimmune arthritis, the SKG mouse. The
SKGmouse develops arthritis as a consequence of having a reduction
in functional ZAP70 protein, and given that ZAP70 is both a direct
target of PTPN22 and a target of the Src-family kinase, Lck, whose
activity is regulated by PTPN22, we anticipated that the combined
mutations might exacerbate development of disease. On the contrary,
we found that SKG mice lacking PTPN22 had both lower incidence
and decreased severity of arthritis following induction of disease by
administration of mannan.
Susceptibility to autoimmune diseases involves complex inter-
actions between genetics and environmental factors. The major
genetic contribution to diseases such as arthritis is the MHC (33), but
recent genome-wide association studies have identified a number of
other contributing genes, the most predominant of which is PTPN22
(10). PTPN22 is present in all hematopoietic cells (34), and the
major disease-associated polymorphism, PTPN22-C1858T, has
been shown to affect myeloid and B cell, as well as T cell, function
(2). The SKG arthritic mouse is a good model for the human RA, as
joint inflammation and damage mirror that found in patients (24).
Similar to humans, arthritic disease in SKG mice is triggered by
environmental factors. Sakaguchi and colleagues (31) showed that
subclinical fungal infections drove the inflammatory signals that
instigated spontaneous arthritis, an effect that was recapitulated by
direct administration of fungal products, such as zymosan or man-
nan, to SPF-bred SKG mice. These fungal products induce IL-6
production, which in turn drives differentiation of autoreactive
T cells to the Th17 lineage. In the context of a more self-reactive
TCR repertoire, which differentiates in the presence of the mutant
ZAP70 alleles (11), SKG Th17 CD4 T cells migrate to the joints
causing the characteristic tissue damage.
The PTPN22C1858T mutation in human cells of the myeloid
lineage has been shown to interfere with upregulation of type 1
IFNs after TLR4 stimulation by LPS, and mouse Ptpn222/2 bone
FIGURE 6. SKG Ptpn222/2 mice have an expansion of CD4+ effector/memory T cells that increases with age. (A) Expression of CD44 and CD62L on
gated CD4+ T cells to distinguish CD62LhiCD44lo naive, and CD62LloCD44hi effector and memory T cells. Data shown were obtained from young
(6-wk-old) and old (.21-wk-old) mice. Representative dot plots (left) and graphs with absolute cell numbers (right) from each genotype are shown. (B)
Intracellular staining of IL-17 and IFN-g in CD4+ LN T cells from older BALB/c, SKG, and SKG Ptpn222/2 mice (.21 wk old) following stimulation
with PDBu/ionomycin. A representative staining from three experimental repeats with minimum of three animals per groups is shown. Horizontal bars
show the group means, and error bars represent the SD. Statistical significance calculated with one-way ANOVA and post hoc Tukey’s test, *p , 0.05,
**p , 0.005.
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marrow–derived macrophages showed a similar defect (35, 36).
This reduction in type 1 IFNs may impede their tissue-protective
effects in the presence of inflammatory cytokines and thus con-
tribute to autoimmune disease susceptibility in humans. In con-
trast, production of proinflammatory cytokines, TNF-a and IL-6,
was shown to be equivalent to WT cells following TLR4 stimu-
lation for either mouse Ptpn222/2 or human PTPN22C1858T my-
eloid cells (36). Given the central role of macrophage-derived IL-6
in driving autoimmune disease in SKG mice (25), we confirmed
that SKG Ptpn222/2 peritoneal macrophages produced equivalent
levels of IL-6 to SKG macrophages in response to mannan stim-
ulation. Mannan is a prototypic activator of the lectin pathway of
complement activation, and incidence of disease is suppressed in
SKG mice lacking the C5a receptor (25); our data would argue
against an involvement of PTPN22 in this signaling pathway.
Deleting PTPN22 expression on the SKG background was
predicted to increase signaling through the TCR and potentially
worsen disease. Indeed, we showed that peripheral SKG Ptpn222/2
CD4 T cells were more responsive to TCR stimulation, but with
the consequence that they produced more IL-2 than SKG T cells.
The production of IL-2 is not only important for Treg development
and maintenance, but has also been reported to inhibit Th17
generation, as blockage of IL-2 or deletion of STAT-5 leads to
enhanced production of Th17 cells (37). Therefore, the change in
cytokine balance in SKG Ptpn222/2 mice was likely to influence
disease progression. That PTPN22-deficient T cells produce more
IL-2 than WT cells upon stimulation has been shown in mice
previously (6), and it is interesting in this regard, that a study
comparing cytokine responses by CD4 T cells from individuals
expressing the disease-associated PTPN22620WW protein also
showed a bias toward Th1 responses with more production of IL-2
and IFN-g and reduced production of IL-17, in comparison with
T cells expressing PTPN22620RR (38). Together these results in-
dicate that signaling through PTPN22 can influence cytokine
production in T cells expressing WT ZAP70 in addition to the
SKG mutation, and that this may influence susceptibility to au-
toimmune disease.
Peripheral tolerance is maintained in vivo by keeping an ap-
propriate balance between self-reactive T cells and Tregs (39), and
Ptpn22 deficiency has been shown to be protective in NOD and
experimental autoimmune encephalomyelitis mice model of dis-
ease due to increased Treg numbers (28, 40). Surprisingly, how-
ever, with the exception of spleen, we did not see a consistent
expansion of Tregs in lymphoid tissue of SKG Ptpn222/2 older
mice beyond that seen in SKG mice, despite the former having
almost twice as many CD44+ effector T cells, nor did we find any
increased potency in suppressive ability between Tregs from SKG
and SKG Ptpn222/2 mice. These results are in contrast to a study
in which the SKG mutation was combined with a deletion of the
negative regulator SLAP (41). SKG SLAP2/2 mice also showed
reduced susceptibility to induction of arthritis, but, in this case,
there was a clear increase in both natural Tregs in the thymus and
induced Tregs in the periphery of SKG SLAP2/2 mice, which
were further expanded after injection of zymosan. In contrast to
the SKG SLAP2/2 mutant mice, where there was ∼300-fold in-
crease in Treg numbers, the increase of Tregs in SKG Ptpn222/2
mice was only ∼20% above that found in SKG mice and not
observed consistently in all lymphoid organs.
Although the SKG mutation is a robust predisposition allele
for development of arthritis following innate stimulation, it is
FIGURE 7. Reduced polarization of IL-17 CD4+ T cells
in vivo and in vitro in SKG Ptpn222/2 mice. (A–C)
Quantification of the percentage of CD4+ T cells in periph-
eral draining (axial, inguinal, brachial, and popliteal) and
mesenteric LN from BALB/c, SKG, and SKG Ptpn222/2
mice that were positive for intracellular staining of IL-
17, TNF-a, and IFN-g following stimulation with PDBu/
ionomycin after 3 wk of mannan challenge. Each symbol
represents individual animals. One representative staining
of three experimental repeats with minimum of three ani-
mals per groups is shown. (D and E) FACS-sorted naive
(CD4+CD252CD45RBhi) cells from 6-wk-old BALB/c,
SKG, and SKG Ptpn222/2 mice were activated with plate-
bound anti-CD3 and anti-CD28 in the presence of TGF-b,
IL-1b, IL-23, and varying amounts of IL-6 for 3 d, and then
restimulated with PDBu/ionomycin for 4 h in presence of
brefeldin A. (D) Quantitation of IL-17+ cells after culture
with varying doses of IL-6, and (E) FACS dot plots are
shown for IL-17 and IFN-g expression with 20 ng/ml IL-6.
Statistical significance calculated with two-way ANOVA;
*p , 0.05, **p , 0.005, ***p , 0.0005.
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clear that in this model the tipping point between generation of
pathogenic T cells and maintenance of tolerance is finely balanced.
To date any modulation of precisely SKG levels of ZAP70 function
has tended to reduce susceptibility to arthritis induction. As de-
scribed above, combining SKG with SLAP knockout diminished
arthritis by improving Treg numbers (41). In another model in
which ZAP70 function is compromised, the knock-in mouse
ZAP70YYAA in which Tyr residues 315 and 319 are substituted
with Ala, ZAP70 function was also considerably impaired com-
pared with WT ZAP70 (20). ZAP70YYAA generated rheumatoid
factor following zymosan injection, but the mice were very re-
sistant to the development of arthritis. Ca2+ flux in DP thymocytes
and responses of peripheral ZAP70YYAAT cells were intermediate
between SKG and WT, similar to the levels we reported in this
work with SKG Ptpn222/2 mutant T cells. Yet ZAP70YYAA thy-
mocytes showed improved deletion of Mtv-reactive TCR Vb
chains, which we did not observe in SKG Ptpn222/2 thymocytes.
ZAP70YYAAT cells were similar to SKG Ptpn222/2 T cells in that
they produced more IL-2 and were slightly less efficient at dif-
ferentiating to the Th17 lineage than SKG T cells, which, together
with improved thymic deletion, gave near-complete protection
against disease. In the case of SKG Ptpn222/2 mice, incidence of
arthritis was reduced, but not as profoundly suppressed as in
ZAP70YYAA mice, consistent with protection stemming from a
combination of a reduction in Th17 effector cell generation to-
gether with a slight improvement in Treg generation rather than a
change in repertoire selection.
The contribution of the PTPN22C1858T variant to RA suscepti-
bility in humans is multifactorial, as this mutation affects several
hematopoietic lineages: T cells, B cells, and myeloid cells, all of
which have been shown to contribute to pathogenicity in RA (42).
Disease in the SKG mouse model is thought to originate primarily
from an altered TCR repertoire due to a shift in thymic selection
toward specificities with higher avidity for self-peptide/MHC,
which, when combined with infection by pathogens, leads to in-
duction of RA, and similar mechanisms may contribute to human
disease (43). In this study, we showed that, whereas loss of PTPN22
improved the activity of mutant ZAP70skg/skg, this had little con-
sequence for selection events in the thymus, and yet significantly
reduced the development of arthritis following mannan injection.
Our studies suggest that the improved incidence and severity of
disease were mainly due to an intrinsic bias of SKG Ptpn222/2
T cells to change their cytokine profile upon stimulation, with a
reduction in the frequency of disease-inducing IL-17 cells and a
trend toward production of IFN-g instead. Combined with a slight
increase in Treg numbers, the reduction in IL-17 production was
sufficient to ameliorate disease severity, thus illustrating how even
very small alterations in T cell signaling may have profound con-
sequences for the maintenance of T cell tolerance.
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